Parkside Financial Bank & Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $167K | Buy |
879
+127
| +17% | +$23.9K | 0.01% | 566 |
|
|
2026
Q1 | $148K | Sell |
752
-49
| -6% | -$9.45K | 0.01% | 544 |
|
|
2025
Q4 | $147K | Buy |
801
+228
| +40% | +$40K | 0.01% | 544 |
|
|
2025
Q3 | $87.9K | Sell |
573
-32
| -5% | -$4.84K | 0.01% | 714 |
|
|
2025
Q2 | $84.6K | Buy |
605
+229
| +61% | +$32.1K | 0.01% | 717 |
|
|
2025
Q1 | $55.2K | Buy |
376
+138
| +58% | +$20K | 0.01% | 798 |
|
|
2024
Q4 | $31.2K | Buy |
238
+17
| +8% | +$2.38K | ﹤0.01% | 955 |
|
|
2024
Q3 | $34.4K | Sell |
221
-3
| -1% | -$484 | ﹤0.01% | 897 |
|
|
2024
Q2 | $34.9K | Buy |
224
+20
| +10% | +$3.01K | 0.01% | 867 |
|
|
2024
Q1 | $27.6K | Buy |
204
+161
| +374% | +$21.3K | ﹤0.01% | 938 |
|
|
2023
Q4 | $5.72K | Buy |
+43
| New | +$5.59K | ﹤0.01% | 1272 |
|
|
2023
Q3 | – | Sell |
-12
| Closed | -$1.65K | – | 2053 |
|
|
2023
Q2 | $1.65K | Buy |
+12
| New | +$1.77K | ﹤0.01% | 1742 |
|
|
2022
Q2 | – | Sell |
-199
| Closed | -$26K | – | 1816 |
|
|
2022
Q1 | $26K | Buy |
199
+195
| +4,875% | +$23.4K | 0.01% | 755 |
|
|
2021
Q4 | $0 | Sell |
4
-32
| -89% | -$3.77K | ﹤0.01% | 1802 |
|
|
2021
Q3 | $4K | Buy |
+36
| New | +$4.19K | ﹤0.01% | 1303 |
|
|
2018
Q3 | – | Sell |
-3,725
| Closed | -$262K | – | 1525 |
|
|
2018
Q2 | $262K | Buy |
3,725
+35
| +0.9% | +$2.52K | 0.1% | 153 |
|
|
2018
Q1 | $258K | Sell |
3,690
-154
| -4% | -$10.7K | 0.1% | 155 |
|
|
2017
Q4 | $267K | Buy |
3,844
+115
| +3% | +$7.75K | 0.1% | 148 |
|
|
2017
Q3 | $253K | Buy |
3,729
+90
| +2% | +$5.69K | 0.1% | 144 |
|
|
2017
Q2 | $248K | Buy |
3,639
+119
| +3% | +$7.77K | 0.1% | 140 |
|
|
2017
Q1 | $219K | Buy |
3,520
+45
| +1% | +$2.62K | 0.09% | 144 |
|
|
2016
Q4 | $190K | Buy |
3,475
+280
| +9% | +$15.9K | 0.08% | 161 |
|
|
2016
Q3 | $210K | Buy |
3,195
+227
| +8% | +$14.8K | 0.1% | 156 |
|
|
2016
Q2 | $179K | Buy |
2,968
+555
| +23% | +$32.2K | 0.09% | 156 |
|
|
2016
Q1 | $136K | Buy |
2,413
+293
| +14% | +$17.6K | 0.07% | 186 |
|
|
2015
Q4 | $144K | Buy |
2,120
+30
| +1% | +$1.97K | 0.07% | 175 |
|
|
2015
Q3 | $133K | Buy |
+2,090
| New | +$137K | 0.08% | 173 |
|
|
2014
Q2 | – | Sell |
-5,915
| Closed | -$384K | – | 177 |
|
|
2014
Q1 | $384K | Buy |
5,915
+950
| +19% | +$61.4K | 0.24% | 92 |
|
|
2013
Q4 | $294K | Buy |
4,965
+30
| +0.6% | +$1.63K | 0.2% | 115 |
|
|
2013
Q3 | $256K | Hold |
4,935
| – | – | 0.2% | 106 |
|
|
2013
Q2 | $234K | Buy |
+4,935
| New | +$251K | 0.18% | 115 |
|
Other funds holding AZN
EP
IA
Parkside Financial Bank & Trust's AZN Position: Q2 2026 in Review
Parkside Financial Bank & Trust increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $23.9K and bringing the position to 879 shares worth $167K. The position accounts for 0.01% of the portfolio, ranked #566.
Parkside Financial Bank & Trust first reported a position in AZN in Q2 2013 and has held it in 31 quarters since. The position peaked at $384K in Q1 2014. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Parkside Financial Bank & Trust held 879 shares of AstraZeneca worth $167K as of Q2 2026.
- Parkside Financial Bank & Trust bought 127 AstraZeneca shares in Q2 2026, an estimated $23.9K.
- AstraZeneca made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #566 holding.
- Parkside Financial Bank & Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 31 quarters since.
- Parkside Financial Bank & Trust's AstraZeneca position peaked at $384K in Q1 2014.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.